Table 2.
Cancer Diagnoses for Current Patient Caseload During Evaluation Period (N = 588).
| Cancer Type | n | % |
|---|---|---|
| Breast | 192 | 32.7% |
| Colon | 48 | 8.2% |
| Prostate | 38 | 6.5% |
| Lung | 35 | 6.0% |
| Skin | 22 | 3.7% |
| Rectum | 21 | 3.6% |
| Brain | 17 | 2.9% |
| Leukemia | 17 | 2.9% |
| Urinary | 17 | 2.9% |
| Ovarian | 16 | 2.7% |
| Pancreas | 15 | 2.6% |
| Oropharynx | 14 | 2.4% |
| Thyroid | 10 | 1.7% |
| Multiple myeloma | 9 | 1.5% |
| Non-Hodgkin’s lymphoma | 9 | 1.5% |
| Stomach | 9 | 1.5% |
| Bladder | 8 | 1.4% |
| Hodgkin’s lymphoma | 8 | 1.4% |
| Lymphosarcoma | 8 | 1.4% |
| Uterus | 7 | 1.2% |
| Esophagus | 6 | 1.0% |
| Other types of cancera | 62 | 10.5% |
a
Other cancers include <1% of patients presenting with the following diagnoses: adenoid cystic, bile duct, biliary tract, bone, cervix, chronic lymphocytic leukemia, eye, gallbladder, kidney, larynx, liver, myelodysplastic syndromes, neuroendocrine, NH lymphoma, peritoneum, synovial sarcoma, testicle, tongue, tonsils, trachea, vulva cancer.